Blog Posts - Femur Fractures



Lawyers For Plaintiffs And Drug Company Merck Make Their Arguments To Third Circuit Appeals Court In Fosamax - Femur Fracture Litigation

One Of The Legal Issues Is Whether Merck Could Have And Should Have Strengthened The Drug Label Warnings About This Apparent Side Effect, Or Not (Posted by Tom Lamb at DrugInjuryWatch.com) The title of out last article about the Fosamax drug injury l...
by Drug Injury Watch on Jan 20, 2016

Fosamax - Femur Fracture Lawsuits Update: California Verdict For Merck In April 2015 With Two More California Trials Scheduled For July 2015 And October 2015

Federal Court Fosamax MDL Reassigned From Judge Pisano To Judge Wolfson While We Wait For Appellate Court To Rule On Appeals From Glynn And Gaynor Case Rulings (Posted by Tom Lamb at DrugInjuryWatch.com) ********** UPDATE: "Remaining Fosamax Cas...
by Drug Injury Watch on Jun 17, 2015

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out

With New Jersey State Court Fosamax Lawsuits Now Assigned To Judge Mayer, We Hope These Cases Get Back On Track (Posted by Tom Lamb at DrugInjuryWatch.com) In our last update, "December 2014 Fosamax - Femur Fracture Litigation Update: In The Fos...
by Drug Injury Watch on Mar 2, 2015

December 2014 Fosamax - Femur Fracture Litigation Update: In The Fosamax Federal Court MDL There Are Dismissals, Appeals, And Court-Ordered Mediations

Judge Pisano's Rulings About Merck's Pre-September 2010 Fosamax Label And Its Subsequent Revised Fosamax Label Are Being Challenged By The Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com) We are drawing from this Merck corporate SEC filing, &qu...
by Drug Injury Watch on Dec 5, 2014

End Of Summer 2014 Update: Fosamax - Femur Fracture Lawsuits In The New Jersey Consolidation / Multicounty Litigation

State Superior Court Judge Nelson Johnson Now Presiding Over About 2880 Cases, According to Merck SEC Report Filed In August 2014 (Posted by Tom Lamb at DrugInjuryWatch.com) There is some news but not much to report about the New Jersey Multicounty L...
by Drug Injury Watch on Aug 29, 2014

Prolia And Femur Fractures: Three Recent Case Reports Indicate A Possible Safety Issue For This Relatively New Drug From Amgen

While Prolia Is An Alternative To Bisphosphonates Such As Fosamax, It Has Similar Increased Risk Of Low-Stress Femur Fractures Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) The association between stress fractures of the femur, or atypical...
by Drug Injury Watch on Aug 12, 2014

June 2014 Fosamax - Femur Fracture Litigation Update: Thousands Of Cases Pending, But No Trial Dates Currently Scheduled In Federal Court MDL Nor New Jersey Multicounty Litigation

Merck Corporate SEC Filing for First Quarter 2014 Provides Information About Numbers Of Lawsuits In Various Court Jurisdictions Being Worked Up For Some Possible Trials In The Future (Posted by Tom Lamb at DrugInjuryWatch.com) We have our first 2014...
by Drug Injury Watch on Jun 6, 2014

Merck Faces More Than 4100 Fosamax - Femur Fracture Lawsuits As Of September 30, 2013 According To SEC Corporate Filing

Next Bellwether Trial Dates: In New Jersey, One To Three Cases Set For March 2014; And, In Fosamax Federal Court MDL, One Case Set For May 2014 (Posted by Tom Lamb at DrugInjuryWatch.com) We have an update from Merck on the Fosamax litigation concern...
by Drug Injury Watch on Dec 2, 2013

March 2013 Fosamax Product Liability Litigation Update: Femur Fracture Cases Against Merck

December 31, 2012 Totals: 2,075 New Jersey (NJ) State Court Lawsuits, With 820 Cases Pending In Federal Court Fosamax MDL And 420 California Claims (Posted by Tom Lamb at DrugInjuryWatch.com) The first Fosamax - femur fracture trial, Su v. Merck, sta...
by Drug Injury Watch on Mar 11, 2013

First Fosamax - Femur Fracture Trial In New Jersey State Court Scheduled To Start March 4, 2013

Judge Higbee Will Preside Over Joint Trial Of Unanski v. Merck Case And Su v. Merck Case; These Two Lawsuits Will Be Tried Together But With Separate Jury Verdicts (Posted by Tom Lamb at DrugInjuryWatch.com) __________________________________________...
by Drug Injury Watch on Feb 18, 2013

Should Merck Have Known And Warned About Fosamax Side Effects Involving The Jaw And Femur Bone Problems Starting When This Drug Was First Put On Market In 1995

Intriguing New Medical/Chemical Journal Article Contends That Medicinal Chemists Or Pharmacologists At The Drug Company Could Have Anticipated Bisphosphonate-Related ONJ And Femur Fracture Cases (Posted by Tom Lamb at DrugInjuryWatch.com) In January...
by Drug Injury Watch on Feb 8, 2013

Fosamax And Femur Fractures: Two New 2012 Medical Journal Articles Go From One Diagnosis To Many Long-Term Outcomes Of Patients

More Findings About Atypical Femoral Fractures And The Use Of Fosamax Or Other Bisphosphonate Therapy For Osteoporosis (But Often Osteopenia) (Posted by Tom Lamb at DrugInjuryWatch.com) In the fall of 2012 we have two more medical journal articles ab...
by Drug Injury Watch on Nov 5, 2012

Intramedullary Nailing Surgery Is Successful Treatment For Patients With Femur Fractures From Use Of Fosamax Or Other Bisphosphonates

People Who Suffer These Atypical Femoral Fractures Are Well Treated With This Surgical Procedure Using Rod-Like Nail, With Low Rate Of Complications (Posted by Tom Lamb at DrugInjuryWatch.com) According a recent article about a presentation -- Clinic...
by Drug Injury Watch on Oct 15, 2012


Trending Topics

Close